Changes in SARS-CoV-2 seroprevalence and population immunity in Finland, 2020-2022
Description
Studying the prevalence of SARS-CoV-2 specific antibodies (seroprevalence) allows for assessing the impact of epidemic containment measures and vaccinations and estimating the number of infections regardless of viral testing. We assessed antibody
